S&P 500 7,641 -2.02% Nasdaq 26,067 -2.75% Dow Jones 52,759 -2.01% FTSE 100 10,779 +0.27% DAX 26,089 -1.33% Nikkei 225 66,016 -4.63% Hang Seng 26,009 +3.55% WTI Crude 87.13 +3.11% Gold 4,636 +4.93% US 10-Year Treasury Yield 4.696 -0.59% S&P 500 7,641 -2.02% Nasdaq 26,067 -2.75% Dow Jones 52,759 -2.01% FTSE 100 10,779 +0.27% DAX 26,089 -1.33% Nikkei 225 66,016 -4.63% Hang Seng 26,009 +3.55% WTI Crude 87.13 +3.11% Gold 4,636 +4.93% US 10-Year Treasury Yield 4.696 -0.59%

LATEST

BJ's Wholesale Club topped profit expectations and raised its full-year earnings outlook●Wall Street's existential crisis over perpetual futures — the 24/7 security on steroids — just got urgent●JPMorgan says Treasury's bond buybacks are just kicking the debt problem down the road●Bessent's 'toolkit,' American brands in China, data center backlash and more in Morning Squawk●ICICI Bank doubles borrowing from overseas markets to $5 billion●Brazilian Investment in Uruguay Has Nearly Doubled to US$4.4 Billion●Labubu-maker Pop Mart stock sinks after overseas sales slumped — and Citi cuts its outlook●Petrobras targets West Africa offshore frontier with four-block talks in Ghana●BJ's Wholesale Club topped profit expectations and raised its full-year earnings outlook●Wall Street's existential crisis over perpetual futures — the 24/7 security on steroids — just got urgent●JPMorgan says Treasury's bond buybacks are just kicking the debt problem down the road●Bessent's 'toolkit,' American brands in China, data center backlash and more in Morning Squawk●ICICI Bank doubles borrowing from overseas markets to $5 billion●Brazilian Investment in Uruguay Has Nearly Doubled to US$4.4 Billion●Labubu-maker Pop Mart stock sinks after overseas sales slumped — and Citi cuts its outlook●Petrobras targets West Africa offshore frontier with four-block talks in Ghana●

Markets

Moderna’s 177% Surge Has Investors Asking What Comes Next

MarketBeat News Feed · 6h ago

Moderna’s 177% Surge Has Investors Asking What Comes Next

Moderna shares surged 177% after its melanoma vaccine, developed with Merck, outperformed an established therapy in a late-stage trial, triggering a massive short squeeze.

Read the full story at MarketBeat News Feed →

More Markets

Sam's Club adds Everyday Dose coffee brand, challenging Starbucks

TST (Full) - (Official Feed) · 58m ago

Two low-cost airlines to shut down in 2027

TST (Full) - (Official Feed) · 1h ago

A Customer Broke His Ankle Boarding a Cruise — Here's Why Travel Insurance Saved Him

TST (Full) - (Official Feed) · 1h ago

Scott Bessent just made a bold move on the bond market

TST (Full) - (Official Feed) · 1h ago